Analysis of the Glutathione Cycle in Children With Rett Syndrome

Edison Pharmaceuticals Inc

Overview

Analyis of the Glutathione Cycle in Children with Rett Syndrome

To analyze the levels of glutathione and relevant glutathione metabolites in children with Rett syndrome in an effort to better understand disease pathology and biochemistry.

Study Type

OBSERVATIONAL

Conditions

Rett Syndrome

Eligibility

Sex: ALLMin age: 2 YearsMax age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age between 2 and 10, inclusive * Genetically-confirmed diagnosis of Rett syndrome with MeCP2 mutation * No change in dietary supplements in three months prior to the initial blood draw * No participation in interventional pharmaceutical clinical trials in prior 12 months Exclusion Criteria: * None other than meeting Inclusion criteria

Locations (1)

University of Alabama, Birmingham

Birmingham, Alabama, United States

Outcomes

Primary Outcomes

Analysis of changes in levels of glutathione and relevant glutathione metabolites in children with Rett syndrome from baseline to the end of month 6

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.